2001
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has revised the schedule for the company's second quarter earnings press release and conference call from...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and the U.S. Food and Drug Administration today met to identify next steps following the recent FDA Circulatory Systems Devices...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), today reported that the Circulatory Systems Device Panel of the U.S. Food and Drug Administration (FDA) elected not to recommend...
Stent's Performance in Europe Supports Growth in Guidant's Stent Market Position Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has...
New Product Offering Further Expands Guidant's Stent Product Line Indianapolis, Ind. and Menlo Park, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Approval Will Allow Physicians to Treat a Greater Number of Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Donation to help low-income individuals receive life-saving cardiac therapies LOS ANGELES, CA - During the Larry King Cardiac Foundation fundraiser, "An Evening with Larry King and Friends,"...
Clinical Trial Will Be Basis for CE Mark Approval of MULTI-LINK TETRA-D(tm) Stent Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
New Device Includes Diagnostic Capabilities for Better Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European CE Mark approval of...
Company Launches MULTI-LINK PENTA Stent Indianapolis, Ind. and Santa Clara, Calif. - Physicians in Europe are getting a glimpse at the latest coronary stent technology, following the European...
Former HCFA Administrator and Current Eli Lilly and Company Executive Vice President Added to the Board Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced that Guidant's...
Emerging Therapies Position Company for Future Success Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), today provided a positive forecast of...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular therapy technology, today announced that it will host a live webcast of its briefing at the...
Company's Second Non-Coronary Stent System Approved Within the Past Month Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company Receives FDA Approval of MULTI-LINK PENTA Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease,...
>Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it will...
Indianapolis, IN and St. Paul, MN - Late this afternoon, various news organizations quoted a U.S. Food and Drug Administration (FDA) spokesperson who commented on Guidant's May 2 release...
PRIZM AVT Pulse Generator Receives European CE Mark Approval Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today...
System Combines Sensor and Diagnostic Capabilities to Enhance Therapy Delivery Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular...
Guidant's System Designed to Treat Heart Failure and Prevent Sudden Cardiac Death. Trial Results Suggest a Slowing of Heart Failure Progression, Improvements in Functional Capacity and Quality of...
Heart Failure Technology Deemed Fileable on an Expedited Basis Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implant of the CONTAK...
Grant to AHA will Empower Americans with Comprehensive Knowledge About Cardiovascular Disease and Heart Failure Indianapolis, Ind. - The Guidant Foundation today announced that it has presented a...
Field Action Results in One-Time Charge to First Quarter Earnings Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology,...
Sales Reach $671 million and Generate Adjusted Earnings per share of $0.41 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment of cardiac...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that it intends to repurchase up to $200 million of its common shares...